MedPath

MIR SCIENTIFIC LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:3
Completed:0

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Evaluation of the Sentinel™ PCC4 Assay for Diagnosis, Prognosis and Monitoring of Prostate Cancer in Puerto Rico

Active, not recruiting
Conditions
Prostate Cancer
First Posted Date
2020-12-10
Last Posted Date
2023-10-25
Lead Sponsor
miR Scientific LLC
Target Recruit Count
500
Registration Number
NCT04661176
Locations
🇵🇷

San Juan Bautista School of Medicine Clinical Research Unit, Caguas, Puerto Rico

🇵🇷

Hospital Menonita de Caguas, Caguas, Puerto Rico

🇵🇷

Hospital Metropolitano Dr. Pila, Ponce, Puerto Rico

Clinical Evaluation of the miR Sentinel BCa™ Test to Diagnose Bladder Cancer in Hematuria Patients

Active, not recruiting
Conditions
Bladder Cancer
First Posted Date
2019-11-07
Last Posted Date
2023-10-25
Lead Sponsor
miR Scientific LLC
Target Recruit Count
444
Registration Number
NCT04155359
Locations
🇺🇸

Integrated Medical Professionals, Farmingdale, New York, United States

Identification of Clinically Insignificant or Significant Prostate Cancer With the miR Scientific Sentinel™ Platform

Active, not recruiting
Conditions
Prostate Cancer
First Posted Date
2019-09-24
Last Posted Date
2023-10-25
Lead Sponsor
miR Scientific LLC
Target Recruit Count
2019
Registration Number
NCT04100811
Locations
🇺🇸

Georgia Urology, Atlanta, Georgia, United States

🇺🇸

Urology of Greater Atlanta, Stockbridge, Georgia, United States

🇺🇸

Integrated Medical Professionals, Farmingdale, New York, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.